$64.06
+ $1.40 (2.23%)
End-of-day quote: 04/26/2024
NasdaqGS:TECH

Bio-Techne Corp Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$1.14B $1.11B $931.03M $738.69M $714.01M $642.99M $563.00M $499.02M $452.25M $357.76M $310.58M $314.56M $289.96M $269.05M $263.96M $257.42M $223.48M $202.62M $178.65M $161.26M
GM % Gross Margin %
67.76% 68.57% 68.14% 65.41% 66.84% 67.59% 67.07% 68.55% 69.48% 72.36% 75.86% 77.37% 78.21% 79.60% 78.81% 79.45% 79.12% 78.28% 79.39% 78.37%
OM Operating Margin
24.73% 25.24% 26.43% 20.41% 21.39% 25.42% 26.54% 31.82% 35.05% 46.99% 52.67% 55.25% 57.46% 58.10% 57.12% 56.05% 55.55% 54.39% 54.72% 51.02%
EPS Earnings Per Share
$0.00 $1.99 $1.97 $1.69 $1.14 $1.13 $1.14 $0.93 $0.90 $0.85 $0.85 $0.80 $0.82 $0.77 $0.74 $0.70 $0.66 $0.54 $0.46 $0.40 $0.33
Div. Dividends
$0.32 $0.32 $0.32 $0.32 $0.32 $0.32 $0.32 $0.32 $0.32 $0.31 $0.30 $0.28 $0.27 $0.26 $0.19 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
16.08% 16.24% 18.93% 28.07% 28.32% 28.07% 34.41% 35.56% 37.65% 36.47% 37.50% 34.15% 35.06% 35.14% 27.14% 0 0.00% 0.00% 0.00% 0
Sha. Shares
157.64m 156.64m 38.96m 38.45m 37.93m 37.61m 37.36m 37.25m 37.15m 37m 36.83m 36.83m 37.15m 37.03m 37.24m 38.64m 39.46m 39.38m 38.64m 41.15m
OCF Operating Cash Flow
$254.39M $325.27M $352.16M $205.22M $181.62M $170.37M $143.72M $144.16M $139.36M $136.76M $123.56M $126.75M $127.19M $111.26M $111.32M $115.32M $90.50M $85.59M $74.43M $65.55M
FCF Free Cash Flow
$216.15M $280.36M $307.86M $153.25M $156.21M $149.43M $128.27M $126.97M $119.45M $122.94M $101.11M $120.73M $123.56M $106.62M $104.76M $98.95M $82.42M $80.99M $63.02M $61.84M
FCFS Free Cash Flow Per Share
$1.38 $1.79 $7.95 $4.02 $4.13 $3.99 $3.44 $3.42 $3.22 $3.33 $2.74 $3.27 $3.33 $2.86 $2.77 $2.53 $2.09 $2.07 $1.56 $1.51